Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.

Abstract

HaemophiliaVolume 20, Issue 6 p. e429-e432 Letter to the Editor Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C R. Sosa, Corresponding Author R. Sosa Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA Correspondence: Romina Sosa, MD, PhD, Division of Hematology-Oncology, 777 Preston Research Building, Nashville, TN 37232-6307, USA. Tel.: 615-936-0975 or 615-322-1483; fax: 615-343-7602; e-mail: iberia.r.sosa@vanderbilt.eduSearch for more papers by this authorD. Gailani, D. Gailani Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USASearch for more papers by this authorA. T. Neff, A. T. Neff Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USASearch for more papers by this author R. Sosa, Corresponding Author R. Sosa Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA Correspondence: Romina Sosa, MD, PhD, Division of Hematology-Oncology, 777 Preston Research Building, Nashville, TN 37232-6307, USA. Tel.: 615-936-0975 or 615-322-1483; fax: 615-343-7602; e-mail: iberia.r.sosa@vanderbilt.eduSearch for more papers by this authorD. Gailani, D. Gailani Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USASearch for more papers by this authorA. T. Neff, A. T. Neff Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USASearch for more papers by this author First published: 21 October 2014 https://doi.org/10.1111/hae.12537Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume20, Issue6November 2014Pages e429-e432 RelatedInformation